Connect
MJA
MJA

Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners

Timothy H J Florin
Med J Aust 2004; 180 (6): 310-312.
Published online: 15 March 2004

Timothy H J Florin

  • Timothy H J Florin

  • Department of Medicine, University of Queensland, Mater Health Services’ Adult Hospital, South Brisbane, QLD 4101.

Correspondence: t.florin@uq.edu.au

Competing interests:

The author is a co-investigator on several clinical trials, including a Pharmacia-sponsored randomised placebo-controlled trial of anti-paratuberculosis treatment for patients with active Crohn’s disease.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.